Analytical methods to determine anti-influenza drugs

Critical Reviews in Analytical Chemistry

Volumn 41, Issue 1, 2011, Pages 81-97

  Navas, M J ^a   Jimeenez A M ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Amantadine; Anti influenza drugs analysis; Oseltamivir; Peramivir; Rimantadine; Zanamivir

Indexed keywords

AMANTADINE; ANTI-INFLUENZA DRUGS ANALYSIS; OSELTAMIVIR; PERAMIVIR; RIMANTADINE; ZANAMIVIR;

AMINES;

ANALYTICAL METHOD; DRUG;

EID: 79951575014     PISSN: 10408347     EISSN: 15476510     Source Type: Journal    
DOI: 10.1080/10408347.2011.539416     Document Type: Article

References (73)

1. Abdel-Ghani, N. T.; Shoukry, A. F.; Hussein, S. H. Flow injection potentiometric determination of amantadine HCl. Journal of Pharmaceutical and Biomedical Analysis 2002, 30, 601-611.
2. Amorim, C. G.; Araújo, A. N.; Montenegro, M. C. B. S. M.; Silva, V. L. Sequential injection lab-on-valve procedure for the determination of amantadine using potentiometric methods. Electroanalysis 2007, 19, 2227-2233.
3. Arndt, T.; Guessregena, B.; Hohla, A.; Reis, J. Determination of serum amantadine by liquid chromatography-tandem mass spectrometry. Clinica Chimica Acta 2005, 359, 125-131.
4. Askal, H. F.;Khedr, A. S.; Darwish, I.A.; Mahmoud, R. M. Quantitative Thin-Layer Chromatography method for determination of amantadine hydrochloride. International Journal of Biomedical Cience 2008, 4(2), 155-160.
5. Aydoǧgmuş, Z. Simple and sensitive spectrofluorometric method for the determination of oseltamivir phosphate in capsules through derivatization with fluorescamine. Journal of Fluorescence 2009, 19, 673-679.
6. Bahrami, G.; Mohammadi, B.; Kiani, A. Determination of oseltamivir carboxylic acid in human serum by solid phase extraction and high performace liquid chromatography with UV detection. Journal of Chromatography B 2008, 864, 38-42.
7. Baughman, T. M.; Wright, W. L.; Hutton, K. A. Determination of zanamivir in rat and monkey plasma by positive ion hydrophilic interaction chromatography (HILIC)/tandemmass spectrometry. Journal of Chromatography B 2007, 852, 505-511.
8. Beigel, J.; Bray, M. Current and future anti-viral therapy of serve seasonal and avian influenza. Antiviral Research 2008, 78, 91-102.
9. Chang, Q.; Chow, M. S. S.; Zuo, Z. Studies on the influence of esterase inhibitor to the pharmacokinetic profiles of oseltamivir and oseltamivir carboxylate in rats using an improved LC/MS/MS method. Biomedical Chromatgraphy 2009, 23, 852-857.
10. Cinatl, J.Jr.; Michaelis, M.; Doerr, H.W. The threat of avian influenza (H5N1). Part III: anti-viral therapy. Med. Microbiol. Immunol. 2007, 196, 203-212.
11. Darwish, I. A.; Khedr, A. S.; Askal, H. F.; Mahmoud, R. M. Simple and sensitive spectrophotometric methods for determination of amantadine hydrochloride. Journal of Applied Spectroscopy 2006, m73(6), 792-797.
12. Darwish, I. A.; Khedr, A. S.; Askal, H. F.; Mahmoud, R. M. Simple fluorimetric method for determination of certain anti-viral drugs via their oxidation with cerium (IV). Il Farmaco 2005, 60, 555-562.
13. Darwish, I. A.; Khedr, A. S.; Askal, H. F.; Mahmoud, R. M. Use of oxidation reactions for the spectrophotometric determination of acyclovir and amantidine hydrochloride in their dosage forms. Anal. Chem: Ind. J. 2005, 1, 1-9.
14. Dong, M. W. Ultrahigh-Pressure LC in Pharmaceutical Analysis: Performance and Practical Issues. LCGC North America 2007, 25(7), 656-666.
15. Dou, Y.; Sun, Y.; Ren, Y.; Ju, P.; Ren, Y. Simultaneous non-destructive determination of two components of combined paracetamol and amantadine hydrochloride in tablets and power by NIR spectroscopy and artificial networks. Journal of Pharmaceutical and Biomedical Analysis 2005, 37, 543-549.
16. Duh, T. H.; Wu, H. L.; Pan, C. W.; Kou, H. S. Fluorimetric liquid chromatographic analysis of amantadine in urine and pharmaceutical formulation. Journal of Chromatography A 2005, 1088, 175-181.
17. Erk, N. A validated HPLC method for the determination of the neuraminidase inhibitor, zanamivir (GG167), in spiked human plasma and pharmaceutical formulations. Journal of Liquid Chromatography & Related Technologies 2004, 27(10), 1541-1552.
18. FDA authorizes emergency use of intravenous anti-viral peramivir for 2009 H1N1 influenza for certain patients, settings. Food and Drug Administration Oct. 23, 2009. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm187813.htm
19. Fedson, D. S. Pandemic Influenza: A potential rol for statins in treatment and prophylaxis. CID 2006, 43, 199-205.
20. Feng, S.; Tian, Y.; Zhang, Z.; Zhang, J.; Huang, M.; Chen, Y. Rapid simultaneous determination of paracetamol, amantadine hydrochloride, caffeine and chlorpheniramine maleate in human plasma by liquid chromatography/tandem mass spectrometry, Arzneimittel Forschung 2009, 59(2), 86-95 (2009:368223 CAN 150:530204 CAPLUS).
21. ®. Legal Medicine 2008, 10, 83-87.
22. Green, M. D.; Nettey, H.; Wirtz, R. A. Determination of Oseltamivir quality by colorimetric and liquid chromatographicmethods. Emerging Infectious Diseases 2008, 14(4), 552-556.
23. Guo, J.-H.; Skinner, G. W.; Harcum, W. W.; Malone, J. P.; Weyer, L. G. Application of Near-Infrared Spectroscopy in the Pharmaceutical Solid Dosage Form. Drug Development and Industrial Pharmacy 1999, 25(12), 1267-1270.
24. Hayden, F. Developing new anti-viral agents for influenza treatment what does the future hold?. CID 2009, 48(Suppl 1), S3-S13.
25. Heinig, K.; Bucheli, F. Sensitive determination of oseltamivir carboxylate in plasma, urine, cerebrospinal fluid and brain by liquid chromatography-tandem mass spectrometry. Journal of Chromatography B 2008, 876, 129-136.
26. Higashi, Y.; Fujii, Y. Liquid chromatographic determination of 1-adamantanamide and 2-adamantanamine in humanplasma after pre-column derivatization with o-phthalaldehyde and 1-thio-β-D-glucose. Journal of Chromatgraphy B 2004, 799, 349-354.
27. Higashi, Y.; Fujii, Y. Simultaneous determination of the binding of amantadine and its analogues to synthetic melanin by liquid chromatography after precolumn derivatization with dansyl chloride. Journal of Chromatographic Science 2005, 43(4), 213-217.
28. Higashi, Y.; Nakamura, S.; Matsumura, H.; Fujii, Y. Simultaneous liquid chromatographic assay of amantadine and its four related compounds in phosphate-buffered saline using 4-fluoro-7-nitro-2,1,3-benzoxadiazole as a fluorescent derivatization reagent. Biomedical Chromatography 2006, 20, 423-428.
29. Higashi, Y.; Uemori, I.; Fujii, Y. Simultaneous determination of amantadine and rimantadine by HPLC in rat plasma with pre-column derivatization and fluorescence detection for pharmacokinetic studies. Biomedical Chromatography 2005, 19, 655-662.
30. Holodniy, M.; Penzak, S. R.; Straight, T. M.; Davey, R. T.; Lee, K. K.; Goetz, M. B.; Raisch, D. W.; Cunningham, F.; Lin, E. T.; Olivo, N.; Deyton, L. R. Pharmacokinetics and tolerability of oseltamivir combinedwith probenecid. Antimicrobial Agents and Chemotherapy 2008, 52(9), 3013-3021.
31. Islam, T.; von Ittzstein, M. Anti-influenza drug discovery: are we ready for the next pandemic? Advances in Carbohydrate Chemistry and Biochemistry 2008, 61, 293-352.
32. Tamiflu® capsules using Micellar Electrokinetic Chromatography. Chem. Pharm. Bull. 2008, 56(12), 1639-1644.
33. Jalali, F.; Maghooli, R. Potentiometric determination of trace amounts of amantadine using a modified carbon-paste electrode. Analytical Science 2009, 25, 1227-1230.
34. ® and generic versions. Journal of Pharmaceutical and Biomedical Analysis 2007, 44, 1008-1013.
35. Kashiwagi, S. Advances in influenza treatment. J. Infect. Chemother. 2001, 7, 199-204.
36. Kiso, M.; Takahashi, K.; Sakai-Tagawa, Y.; Shinya, K.; Sakabe, S.; Le, Q. M.; Ozawa, M.; Furuta, Y.; Kawaoka, Y. T-705 (favipiravir) activity against lethalH5N1 influenza A viruses. PNAS 2010, 107(2), 882-887.
37. Kubo, S.; Tomozawa, T.; Kakuta, M.; Tokumitsu, A.; Yamashita, M. Laninamivir Prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior ant-influenza virus activity after a single administration. Antimicrobial Agents and Chemotherapy 2010, 54(3), 1256-1264.
38. Kulapina, E. G.; Barinov, O. V. Structure of chemical compounds, methods of analysis and process controlion-selective electrodes in drug analysis (a review). Pharmaceutical Chemistry Journal 1997, 31(12), 667-672.
39. ® and generic version. Journal of Pharmaceutical and Biomedical Analysis 2009, 50, 544-546.
40. Li, Y.; Zhang, X.; Wang, X.; Li, S.; Ruan, J.; Zhang, Z. Quantification of peramivir (a novel anti-influenza drug) in human plasma by hydrophilic interaction chromatography/tandem mass spectrometry. Journal of Chromatography B 2009, 877, 933-938.
41. Lin, F. M.; Kou, H. S.; Wu, S. M.; Chen, S. H.; Kwan, A. L.; Wu, H. L. An ionizable chromophoric reagent for the analysis of primary amine-containing drugs by capillary electrophoresis. Electrophoresis 2008, 26, 621-626.
42. Lindegardh, N.; Hanpithakpong, W.; Phakdeeraj, A.; Singhasivanon, P.; Farrar, J.; Hien, T. T.; White, N. J.; Day, N. P. J. Development and validation of a high-throughput zwitterionic hydrophilic interaction liquid chromatography solid phase extraction-liquid chromatographytandem mass spectrometry method for determination of the antiinfluenza drug peramivir in plasma. Journal of Chromatography A 2008, 1215, 145-151.
43. Lindegardh, N.; Hanpithakpong, W.; Wattanagoon, Y.; Singhasivanon, P.; White, N. J.; Day, N. P. J. Development and validation of a chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine. Journal of Chromatography B 2007, 859, 74-83.
44. ®. Journal of Pharmaceutical and Biomedical Analysis 2006, 42, 430-433.
45. Mahmoud, A. M.; Khalil, N. Y.; Darwish, I. A.; Aboul-Fadl, T. Selective Spectrophotometric and spectrofluorimetric methods for the determination of amantadine hydrochloride in capsules and plasma via derivation with 1,2-naphthoquinone-4-sulphonate. International Journal of Analytical Chemistry 2009, 2009, 1-8.
46. Mustafa, A. A.; Abdel-Fattah, S. A.; Toubar, S. S.; Sultan, M. A. Spectrophotometric determination of acyclovir and amantadine hydrochloride through metals complexation. Journal of Analytical Chemistry 2004, 59(1), 33-38.
47. Nagarajan, J. S. K.; Muralidharan, S. A validated RP-HPLC method for estimation of oseltamivir in pharmaceutical formulation. Der Pharmacia Lettre 2009, 1(1), 162-168.
48. Narasimhan, B.; Abida, K.; Srinivas, K. Stability indicating RP-HPLC method development and validation for oseltamivir API. Chem. Pharm. Bull. 2008, 56(4), 413-417.
49. Oo, C.; Hill, G.; Dorr, A.; Liu, B.; Boellner, S.; Ward, P. Pharmacokinetic of anti-influenza prodrug oseltamivir in children aged 1-5 years. Eur J Clin Pharmacol 2003, 59, 411-415.
50. Pazourek, J.; Revilla, A. L.; Gajdosova, D.; Havel, J. Validation of a capillary zone electrophoresis method for the determination of rimantadine hydrochloride in rimantadin100 tablets and the method application to dissolution test monitoring. Drug Development and Industrial Pharmacy 2004, 30(2), 125-134.
51. Peng, A. W.; Milleri, S.; Stein, D. S. Direct measurement of the antiinfluenza agent zanamivir in the respiratory tract following inhalation. Antimicrobial Agents and Chemotherapy 2000, 44, 1974-1976.
52. Ping, W.; Yi-Zeng, L.; Ben-Mei, C.; Neng, Z.; Lun-Zhao, Y.; Yan, Y.; Zhi-Biao, Y. Quantitative determination of amantadine in human plasma by liquid chromatography-mass spectrometry and the application in a bioequivalence study. Journal of Pharmaceutical and Biomedical Analysis 2007, 43, 1519-1525.
53. Poáskova, P.; Bocaz, G.; Li, H.; Havel, J. Evaluation of calibration data in capillary electrophoresis using artificial neural networks to increase precision of analysis. Journal of Chromatography A 2002, 979, 59-67.
54. Raghuram, P.; Soma Raju, I. V.; R. Ratnakar,; Sriramulu, J. A stability indicating LC method for oseltamivir phosphate. Analytical Chemistry: An Indian Journal 2008, 7(8), 617-624 (2009:553867 CAPLUS).
55. ® by uv-spectrophotometer. International Journal of PharmTech Research 2010, 2(1), 363-366.
56. Reichova, N.; Pazourek, J.; Poláskova, P.; Havel, J. Electrophoretic behavior of adamantane derivatives possessing anti-viral activity and their determination by capillary zone electrophoresis with indirect detection. Electrophoresis 2002, 23, 259-262.
57. Rizk, M. S.; Toubar, S. S.; Sultan, M. A.; Assaad, S. H. Ultraviolet spectrophotometric determination of primary amine-containing drugs via their charge-transfer complexes with tetracyanoethylene. Microchimica Acta 2003, 143, 281-285.
58. Salem, A. A. Modified carbon paste versus graphite coated ion selective electrodes for the determination of amantadine and moroxydine hydrochlorides in pharmaceutical and urine samples. Canadian Journal of Analytical Sciences and Spectroscopy 2005, 50(3), 147-158.
59. Shuangjin, C.; Fang, F.; Han, L.; Ming, M. New method for highperformance liquid chromatographic determination of amantadine and its analogues in rat plasma. Journal of Pharmaceutical and Biomedical Analysis 2007, 44, 110-1105.
60. Stiver, G. The treatment of influenza with anti-viral drugs. CMAJ 2003, 168(1), 49-57.
61. ®) for sewage works and surface waters under seasonalinfluenza-and pandemic-use conditions. Ecotoxicology and Environmental Safety 2009, 72, 1625-1634.
62. Titova, A. V.; Arzamastsev, A. P.; Gretskii, S. V. Structure of chemical compounds, methods of analysis and process control. Analysis of rimantadine hydrochloride by near-IR spectroscopy. Pharmaceutical Chemistry Journal 2009, 43(9), 534-537.
63. Triana-Baltzer, G. B.; Gubareva, L. V.; Nicholls, J. M.; Pearce, M. B.; Mishin, V. P.; Belser, J. A.; Chen, L.-M.; Chan, R.W. Y.; Chan, M. C. W.; Hedlund, M.; Larson, J. L.; Moss, R. B.; Katz, J. M.; Tumpey, T. M.; Fang, F. Novel pandemic influenzaA(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein. PLOS ONE 2009, 4(11), e7788:1-8.
64. Vannecke, C.; Bloomfield, M. S.; Vander Heyden, Y.; Massart, D. L. Development of a generic flow injection analysis method for compounds with a secondary amine or amide function, using an experimental design approach Part II. Selection and evaluation of the chemical reaction parameters. Analytica Chimica Acta 2002, 455, 117-130.
65. Vannecke, C.; Van Gyseghem, E.; Bloomfield, M. S.; Coomber, T.; Vander Heyden, Y.; Massart, D. L. Development of a generic flow injection analysis method for compounds with a secondary amine or amide function, using an experimental design approach I. Selection and evaluation of the FIA system parameters. Analytica Chimica Acta 2001, 446, 413-428.
66. Wang, T.; Feng, H.; Li, S. F. Y. Indirect capillary electrophoresis with 8-anilo-1-naphthalenesulfonic acid as a fluorescence probe for determining the apparent stability constant of an inclusion complex formed between a cyclodextrin and a solute. Journal of Chromatography A 2003, 987, 485-495.
67. Wiltshire, H.; Wiltshire, B.; Citron, A.; Clarke, T.; Serpe, C.; Gray, D.; Herron, W. Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine. Journal of Chromatography B 2000, 745, 373-388.
68. Winiarski, A. P.; Infeld, M. H.; Tscherme, R.; Bachynsky, M.; Rucki, R.; Nagano-Mate, K. Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules. Journal of the American Pharmacists Association 2007, 47(6), 747-755.
69. Worley, K. C.; Robert, S.; Bawdon, R. E. The metabolism and transplacental transfer of oseltamivir in the ex vivo human model. Infectious Diseases in Obstetrics and Gynecology 2008, 2008, 1-5.
70. Xu, M.; Ju, W.; Xia, X.; Tan, H.; Chen, M.; Zhang, J.; Xiong, N.; Jiang, M.; Chen, L.; Gong, L. Determination of rimantadine in rat plasma by liquid chromatography/electrospray mass spectrometry and its application in a pharmacokinetic study. Journal of Chromatography B 2008, 864, 123-128.
71. Yamazaki, Y.; Ishii, T.; Honda, A. The influence of oseltamivir carboxylate and oseltamivir on hemagglutinin inhibition and microneutralization test. Antiviral Research 2008, 80, 354-359.
72. Yao, W.; Luo, X.; Hu, Y. Determination of Amantadine sulfate in sodium chloride injection by capillary gas chromatography. J. Pharma. Sci. Technol 2006, 60(3), 138-43. (http://journal.pda.org/content/60/3/138.abstract)
73. Yoshida, H.; Nakao, R.; Matsuo, T.; Nohta, H.; Yamaguchi, M. 4-(6,7-Dihydro-5,8-dioxothiazolo[4,5-g]phthalazarin-2-yl)benzoica cid Nhydroxysuccinimide ester as a highly sensitive chemiluminescence derivatization reagent for amines in liquid chromatography. Journal of Chromatography A 2001, 907, 39-46.